| Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study T Voit, H Topaloglu, V Straub, F Muntoni, N Deconinck, G Campion, ... The Lancet Neurology 13 (10), 987-996, 2014 | 373 | 2014 |
| Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations V Ricotti, WPL Mandy, M Scoto, M Pane, N Deconinck, S Messina, ... Developmental Medicine & Child Neurology 58 (1), 77-84, 2016 | 273 | 2016 |
| Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy V Ricotti, DA Ridout, E Scott, R Quinlivan, SA Robb, AY Manzur, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (6), 698-705, 2013 | 264 | 2013 |
| Development of the P erformance of the U pper L imb module for D uchenne muscular dystrophy A Mayhew, ES Mazzone, M Eagle, T Duong, M Ash, V Decostre, ... Developmental Medicine & Child Neurology 55 (11), 1038-1045, 2013 | 224 | 2013 |
| Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation M Pane, ME Lombardo, P Alfieri, A D'Amico, F Bianco, G Vasco, G Piccini, ... The Journal of pediatrics 161 (4), 705-709. e1, 2012 | 170 | 2012 |
| The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials V Ricotti, DA Ridout, M Pane, M Main, A Mayhew, E Mercuri, AY Manzur, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 149-155, 2016 | 154 | 2016 |
| Early neurodevelopmental assessment in Duchenne muscular dystrophy M Pane, R Scalise, A Berardinelli, G D’Angelo, V Ricotti, P Alfieri, I Moroni, ... Neuromuscular Disorders 23 (6), 451-455, 2013 | 98 | 2013 |
| Further delineation of Pitt–Hopkins syndrome: phenotypic and genotypic description of 16 novel patients C Zweier, H Sticht, EK Bijlsma, J Clayton-Smith, SE Boonen, A Fryer, ... Journal of medical genetics 45 (11), 738-744, 2008 | 98 | 2008 |
| A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy ES Mazzone, G Vasco, C Palermo, F Bianco, C Galluccio, V Ricotti, ... Developmental Medicine & Child Neurology 54 (10), 879-885, 2012 | 94 | 2012 |
| Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping K Anthony, V Arechavala-Gomeza, V Ricotti, S Torelli, L Feng, N Janghra, ... JAMA neurology 71 (1), 32-40, 2014 | 88 | 2014 |
| Duchenne muscular dystrophy and epilepsy M Pane, S Messina, C Bruno, A D’amico, M Villanova, B Brancalion, ... Neuromuscular Disorders 23 (4), 313-315, 2013 | 80 | 2013 |
| Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti‐N‐methyl‐d‐aspartate receptor encephalitis C Poloni, CM Korff, V Ricotti, MD King, ER Perez, C MAYOR‐DUBOIS, ... Developmental Medicine & Child Neurology 52 (5), e78-e82, 2010 | 76 | 2010 |
| Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole utrophin modulator, following single-and multiple-dose administration to pediatric patients with … V Ricotti, S Spinty, H Roper, I Hughes, B Tejura, N Robinson, G Layton, ... PloS one 11 (4), e0152840, 2016 | 70 | 2016 |
| Upper limb evaluation in Duchenne muscular dystrophy: fat-water quantification by MRI, muscle force and function define endpoints for clinical trials V Ricotti, MRB Evans, CDJ Sinclair, JW Butler, DA Ridout, JY Hogrel, ... PLoS One 11 (9), e0162542, 2016 | 65 | 2016 |
| Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 C Brogna, G Coratti, M Pane, V Ricotti, S Messina, A D’Amico, C Bruno, ... PLoS One 14 (6), e0218683, 2019 | 61 | 2019 |
| Revised North Star Ambulatory Assessment for young boys with Duchenne muscular dystrophy E Mercuri, G Coratti, S Messina, V Ricotti, G Baranello, A D’Amico, ... PLoS One 11 (8), e0160195, 2016 | 60 | 2016 |
| Use of complementary and alternative medicine in epilepsy V Ricotti, N Delanty Current Neurology and Neuroscience Reports 6 (4), 347-353, 2006 | 58 | 2006 |
| Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts V Cazzella, J Martone, C Pinnarò, T Santini, SS Twayana, O Sthandier, ... Molecular Therapy 20 (11), 2134-2142, 2012 | 57 | 2012 |
| Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system V Ricotti, H Jägle, M Theodorou, AT Moore, F Muntoni, DA Thompson European Journal of Human Genetics 24 (4), 562-568, 2016 | 53 | 2016 |
| Performance of Upper Limb module for Duchenne muscular dystrophy AG Mayhew, G Coratti, ES Mazzone, K Klingels, M James, M Pane, ... Developmental medicine & child neurology 62 (5), 633-639, 2020 | 47 | 2020 |
